Xarelto Lawsuit Plaintiffs Scheduled To See Bellwether Trial Hearings In Early 2017

April 29, 2016 – – BloodThinnerHelp.com reports on the scheduled bellwether lawsuit trials for lawsuits consolidated in Xarelto multidistrict litigation number 2592. Bellwether trials will hear 4 cases chosen from a bellwether pool of 40 which are intended to best represent all plaintiffs who have currently filed Xarelto-related lawsuits. The hearings are intended to provide all involved with a better idea of how juries might react to certain pieces of evidence and testimony moving forward. Lawsuits involved in MDL 2592 currently number over 2,800 and are being overseen in Eastern Louisiana by the Honorable Judge Eldon Fallon. They share strikingly similar plaintiff allegations made against defendants Bayer AG and Johnson & Johnson’s subsidiary company Janssen Pharmaceuticals.

In 2011, Xarelto launched onto the market after gaining approval by the U.S. Food and Drug Administration. The drug was a revolutionary, new-generation blood thinner which was able to provide patients with freedoms that other blood thinners had been unable to. Unlike traditional blood thinners, Xarelto required no special diets, dosage adjustments, or regular monitoring and check-ins with a physician. It also, however, was released to market with no corresponding antidote; a dangerous move that many plaintiffs today call recklessly negligent.

Xarelto remained on the market without any antidote for over 4 years, according to reports. Patients taking the drug, therefore, had to be very careful of being injured while on it, which is sometimes hard to avoid. Without an antidote to clot the blood and counter the effects of Xarelto, even a minor injury could become life-threatening due to blood loss. Traditional blood thinners offer a corresponding antidote through vitamin K. When patients using these blood thinners injure themselves and begin to bleed, doctors are able to counter the blood thinner’s effects with vitamin K and clot their blood, potentially saving their lives.

Since this time, Xarelto has been linked to increased risk of serious and potentially fatal bleeding events by the thousands of plaintiffs filing lawsuits. As these plaintiffs await trial dates, Attorney Joseph Osborne is working to help other patients who have used Xarelto and who feel that the drug has caused them to suffer from health complications. Those affected may be entitled to substantial compensation gained through legal action, and are encouraged to take the opportunity to explore their legal rights in the matter fully. Those who wish to look into their options further are offered complimentary legal consultations at this time from Attorney Osborne.

To request additional information, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009694